AZD9550 Clinical Trials

2 actively recruiting trials across 1 location

▲ +1 trial since May 2026

Pipeline

Phase 1: 1Phase 1/2: 1

Top Sponsors

AstraZeneca2

Indications

Liver Disease1
Hepatic Impairment1
Weight Loss1
Diabetes1
Overweight and Obesity1

Other1 trial

A Trial to Learn How Safe AZD9550 Monotherapy and Combined With AZD6234 is in People With or Without Type 2 Diabetes Who Are Living With Obesity and Overweight

Phase 1/2

Chandler, Arizona1 trial

A Phase I Study to Investigate the Effect of Hepatic Impairment of AZD9550 and AZD6234

Research Site

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.